Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different …

N Gossger, MD Snape, LM Yu, A Finn, G Bona… - Jama, 2012 - jamanetwork.com
Context In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB)
remains a major cause of invasive disease in early childhood in developed countries. …

[HTML][HTML] Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy

CA Jeppesen, MD Snape, H Robinson, N Gossger… - Journal of infection, 2015 - Elsevier
Objectives Recent development of serogroup B meningococcal (MenB) vaccines highlights
the importance of pharyngeal carriage data, particularly in adolescents and young adults, to …

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose

…, P Saroey, TM John, H Robinson, S Kelly, N Gossger… - Cmaj, 2013 - Can Med Assoc
Background: The multicomponent serogroup B meningococcal (4CMenB) vaccine was recently
licensed for use in Europe. There are currently no data on the persistence of bactericidal …

Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of …

…, H Robinson, S Kelly, N Gossger… - The pediatric …, 2013 - journals.lww.com
Background: In a previous study, 60 infants receiving an investigational serogroup B
meningococcal vaccine containing recombinant meningococcal proteins alone (rMenB) or …

Inching toward a serogroup B meningococcal vaccine for infants

AC Cohn, NE Messonnier - JAMA, 2012 - jamanetwork.com
… The results of the study by Gossger et al 6 demonstrate this serogroup B vaccine is immunogenic
in infants; however, there is still much to understand about effective implementation of …

Meningococcal B vaccination: real-world experience and future perspectives

P Kuhdari, A Stefanati, S Lupi, N Valente… - Pathogens and Global …, 2016 - Taylor & Francis
Invasive meningococcal disease (IMD) represents a severe risk for health. It can be considered
the most dangerous vaccine-preventable disease due to the high probability of related …

[HTML][HTML] 73rd Congress of the Italian Society of Pediatrics

F Albano - Italian Journal of Pediatrics, 2017 - Springer
The Italian Ombudsperson for Childhood and Adolescence was established by Law no. 112
of 12 July 2011, with a view to ensuring the full implementation and protection of the rights …

[PDF][PDF] Fast and accurate dynamic estimation of field effectiveness for meningococcal vaccines Supplementary Information

L Argante, M Tizzoni, D Medini - 2016 - researchgate.net
The relative risk is a ratio of two risks: the risk that a certain event occurs in a group of people
divided by the risk that the same event happens in a second distinct group of people. In this …

Bildgebende Verfahren in der Diagnostik von Myopathien

NP Gossger - 2005 - opus.bibliothek.uni-wuerzburg.de
Ziel dieser Arbeit war es, die Aussagefähigkeit der Kernspintomographie mit der der
Histologie und der Sonographie im Hinblick auf Umbauvorgänge im Muskel in einem …

[CITATION][C] Pivotal Study Published In JAMA Confirms Potential Of Novartis Candidate Vaccine Bexsero To Help Protect Infants Against Devastating Meningococcal …

FI Human